Pulmonary Arterial Hypertension Whitepaper, Healthcare Whitepaper and Pharmaceutical Whitepaper

Pulmonary Arterial Hypertension (PAH) is a rare, chronic, and progressive form of Pulmonary Hypertension, delineated by the elevated pulmonary arterial pressure (PAP) and pulmonary vascular resistance (PVR) in blood vessels carrying the blood from the right side of the heart through lungs. PAH affects around 1,000 people every year in the United States. Know moreContinue reading “Pulmonary Arterial Hypertension Whitepaper, Healthcare Whitepaper and Pharmaceutical Whitepaper”

Design a site like this with WordPress.com
Get started